live biotherapeutics

Seres Therapeutics Reports Positive Early SER-155 Data

CAMBRIDGE, Mass., July 8, 2026 Seres Therapeutics announced encouraging topline results from an investigator-sponsored clinical trial (IST) evaluating SER-155...

By cGxPwire Editor
July 9, 2026

Bio-Pharma

MRM Health Launches Phase 2b UC Trial with MH002

GHENT, Belgium, May 2, 2026 MRM Health announced the initiation of its Phase 2b STARFISH-UC clinical trial (NCT07296315) evaluating...

By cGxPwire Editor
May 2, 2026

Bio-Pharma

Vedanta Biosciences Advances Microbiome Drugs at ESCMID 2026

CAMBRIDGE, Mass., April 9, 2026 Vedanta Biosciences, a late clinical-stage biopharmaceutical company, has announced new scientific presentations showcasing its...